[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Mufaso7 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::984787662656688128.png) @Mufaso7 Mufaso

Mufaso posts on X about eli lilly, investment, $vktx, compound the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::984787662656688128/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +23%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +27%

### Mentions: X [#](/creator/twitter::984787662656688128/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:posts_active.svg)

- X Week X no change
- X Month X no change
- X Months XX -XX%
- X Year XX +69%

### Followers: XXXXX [#](/creator/twitter::984787662656688128/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:followers.svg)

- X Week XXXXX +0.09%
- X Month XXXXX +0.69%
- X Months XXXXX +4.50%
- X Year XXXXX +39%

### CreatorRank: undefined [#](/creator/twitter::984787662656688128/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::984787662656688128/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::984787662656688128/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXXXX%

**Social topic influence**
[eli lilly](/topic/eli-lilly) 16.67%, [investment](/topic/investment) 16.67%, [$vktx](/topic/$vktx) 16.67%, [compound](/topic/compound) 16.67%, [events](/topic/events) XXXXX%

**Top accounts mentioned or mentioned by**
[@gilamonstrum](/creator/undefined) [@biopharmiq](/creator/undefined) [@cigs1234](/creator/undefined) [@joeyang043](/creator/undefined) [@pharmdca](/creator/undefined) [@semodough](/creator/undefined) [@maximusholla](/creator/undefined) [@aschulz888](/creator/undefined) [@fluffer9](/creator/undefined) [@mtheory11bio](/creator/undefined) [@pharmdabbler](/creator/undefined) [@dewdiligence](/creator/undefined) [@knielsen2000](/creator/undefined) [@jfais20](/creator/undefined) [@cryptobiotech](/creator/undefined) [@bioinvestor24](/creator/undefined) [@duedoctor](/creator/undefined)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/eli-lilly) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx)
### Top Social Posts [#](/creator/twitter::984787662656688128/posts)
---
Top posts by engagements in the last XX hours

"$VKTX- Near term catalysts: Should start Ph2 Maintenance study in Obesity for #VK2735 this month that includes monthly subq and low dose oral options. (this one could happen any day now.) Should have IND and ph1 study in Amylin/Dacra Compound by EOY Vanquish PH3 subq study initiated Jun 25th. Enrollment going well and next up is announcement of completion full enrollment. Other events that could drive the stock higher: - Renewed interest in MASH drugs due to MDGL success (and FDA relaxing Biopsy reqs for ph3) could lead to partnership of #VK2809 - Interest rates continue to decline and lead"  
[X Link](https://x.com/Mufaso7/status/1976609314992189600) [@Mufaso7](/creator/x/Mufaso7) 2025-10-10T11:22Z 3342 followers, 31.6K engagements